Skip to main content

Table 1 Characteristics of the total cohort and by sex

From: Systemic arteriosclerosis is associated with left ventricular remodeling but not atherosclerosis: a TASCFORCE study

  Total Men Women p-value
N 1515 574 941  
Age (years) 54.1 ± 8.3 53.8 ± 8.2 54.3 ± 8.4 0.24
Heart rate (bpm) 63.4 ± 10.0 61.4 ± 9.7 64.6 ± 9.9 < 0.001
Systolic BP (mmHg) 122 ± 12 125 ± 11 121 ± 12.5 < 0.001
Diastolic BP (mmHg) 73 ± 9 75 ± 9 72 ± 9 < 0.001
BMI (kg/m2) 26.8 ± 4.3 27.1 ± 3.6 26.6 ± 4.6 0.025
Current smoker (%) 165 (10.9%) 51 (8.9%) 114 (12.1%) 0.057
Ex smoker (%) 414 (27.4%) 162 (28.3%) 252 (26.8%) 0.52
Non-smoker (%) 935 (61.8%) 360 (62.8%) 575 (61.1%) 0.53
Smoking pack years 6.03 ± 11.9 6.64 ± 13.7 5.65 ± 10.6 0.12
Family history of CVD 387 (25.5%) 131 (22.8%) 256 (27.2%) 0.058
Total cholesterol (mmol/L) 5.48 ± 0.97 5.40 ± 0.92 5.53 ± 1.0 0.016
LDL-Cholesterol (mmol/L) 3.40 ± 0.88 3.40 ± 0.83 3.39 ± 0.90 0.83
HDL-Cholesterol (mmol/L) 1.44 ± 0.43 1.25 ± 0.39 1.56 ± 0.41 < 0.001
Triglycerides (mmol/L) 1.47 ± 0.86 1.71 ± 0.96 1.32 ± 0.75 < 0.001
Random glucose (mmol/L) 5.18 ± 0.90 5.27 ± 0.78 5.11 ± 0.97 0.018
BNP (pg/ml) 27.4 ± 17.9 19.8 ± 13.7 32.1 ± 18.5 < 0.001
ASSIGN risk score (%) 9.3 ± 6.6 11.4 ± 6.5 7.9 ± 6.3 < 0.001
LVEDV (g/m2) 71.6 ± 12.4 77.3 ± 13.2 68.1 ± 10.5 < 0.001
LVESV (g/m2) 22.6 ± 7.1 25.0 ± 7.4 21.1 ± 6.6 < 0.001
LVSV (g/m2) 49.0 ± 8.3 52.2 ± 8.9 47.0 ± 7.2 < 0.001
LVEF (%) 68.8 ± 6.5 67.9 ± 6.2 69.3 ± 6.6 < 0.001
LV mass (g/m2) 55.1 ± 11.6 64.3 ± 10.6 49.5 ± 8.0 < 0.001
LVMVR (g/ml) 0.78 ± 0.15 0.85 ± 0.16 0.74 ± 0.13 < 0.001
Compliance (ml/m2/mmHg) 1.03 ± 0.28 1.17 ± 1.96 0.99 ± 0.27 < 0.001
SAS 1.27 ± 2.1 1.17 ± 1.96 1.34 ± 2.18 0.14
SIMD
 1 65 (4.3%) 20 (2.1%) 45 (4.8%) 0.72
 2 78 (5.2%) 25 (4.4%) 53 (5.7%)
 3 101 (6.7%) 36 (6.3%) 65 (6.9%)
 4 77 (5.1%) 34 (5.9%) 43 (4.6%)
 5 93 (6.2%) 34 (5.9%) 59 (6.3%)
 6 165 (10.9%) 63 (11%) 102 (10.9%)
 7 246 (16.3%) 88 (15.3%) 158 (16.8%)
 8 295 (19.5%) 115 (20%) 180 (19.2%)
 9 275 (18.2%) 109 (19%) 166 (17.7%)
 10 117 (7.7%) 50 (3.3%) 67 (7.1%)
  1. ASSIGN Assessing cardiovascular risk using SIGN guidelines, BMI body mass index, BNP brain natriuretic peptide, BP blood pressure, CVD cardiovascular disease, HDL high density lipoprotein, LDL low density lipoprotein, LVEDV left ventricular end diastolic volume, LVESV left ventricular end systolic volume, LVSV left ventricular stroke volume, LVEF left ventricular ejection fraction, LVMVR left ventricular mass to volume ratio, SAS standardised atheroma score, SIMD Scottish Index of Multiple Deprivation
  2. P-values < 0.05 highlighted in bold